Determination of the shelf life of the API morpholinium 2-((4-(2-methoxyphenyl)-5-(4-pyridyl)-4H-1,2,4-triazol-3-yl)thio)acetate
DOI:
https://doi.org/10.14739/2409-2932.2025.2.325965Keywords:
drug shelf life, morpholinium 2-(4-(2-methoxyphenyl)-5-(4-pyridyl)-4H-1,2,4-triazol-3-yl)thio)acetate, accelerated aging of medicinal productsAbstract
This study determined the shelf life of the active pharmaceutical ingredient (API) morpholinium 2-(4-(2-methoxyphenyl)-5-(4-pyridyl)-4H-1,2,4-triazol-3-yl)thio)acetate by determining its quantitative storage characteristics.
Aim. The aim of the work was to determine the shelf life of the API morpholinium 2-(4-(2-methoxyphenyl)-5-(4-pyridyl)-4H-1,2,4-triazol-3-yl)thio)acetate using the accelerated aging method.
Materials and methods. The work used the physicochemical method of accelerated aging, as well as the method of spectrophotometry in the UV region (SPECORD 200-222U214 device) to establish quantitative indicators of the API during its storage, the characteristics of the linear dependence and metrological characteristics of the UV-SF method are given using the method of mathematical statistics. API samples were taken using analytical balances KERN AVT 120-5DM.
Results. It was established that after the completion of the experimental storage period (at 40 °C), which corresponds to a shelf life of two years (storage at room temperature), the active pharmaceutical ingredient, namely the morpholinium salt of 2-(4-(2-methoxyphenyl)-5-(4-pyridyl)-4H-1,2,4-triazol-3-yl)thio)acetic acid, complies with the requirements of the temporary pharmacopoeial monograph. Based on this, the proposed shelf life in the project is set at two years. Considering that morpholinium 2-(4-(2-methoxyphenyl)-5-(4-pyridyl)-4H-1,2,4-triazol-3-yl)thio)acetate contains a divalent sulfur atom in its structure, it may be susceptible to oxidation. Therefore, medicinal products based on this API should be stored in a place protected from light.
Conclusions. The study results provide a basis for asserting that morpholinium 2-(4-(2-methoxyphenyl)-5-(4-pyridyl)-4H-1,2,4-triazol-3-yl)thio)acetate can be stored at room temperature for at least two years without loss of quality.
References
Ahmad M, Khaled S, Raja J, Junaid A, Mazin D, Al-Hammadi Y, et al. A blockchain-based approach for drug traceability in healthcare supply chain. IEEE Access. 2021;9:9728-43. doi: https://doi.org/10.1109/ACCESS.2021.3049920
Sachuk RM, Velesik TA, Stravsky YS, Gutiy BV, Katsaraba OA, Ponomareva SA, et al. Pharmacotechnological quality indicators of the veterinary drug based on calcium gluconate. Sci Tech Bull State Sci Res Control Inst Vet Med Prod Feed Addit Inst Anim Biol. 2023;24(1):163-70. Ukrainian. doi: https://doi.org/10.36359/scivp.2023-24-1.22
Кychan МВ, Vasiv RО, Sachuk RM, Kalynovska LV. Pharmacochemical and technological quality indicators of the veterinary medicinal product based on birch tar. Sci Tech Bull State Sci Res Control Inst Vet Med Prod Feed Addit Inst Anim Biol. 2024;25(1):52-61. Ukrainian. doi: https://doi.org/10.36359/scivp.2024-25-1.07
Usenko DL, Kaplaushenko AH, Varynskyi BO. [Determination of the isotonicity 1 % solution of sodium 2-((4-amino-5-thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-yl)thio)acetate]. Current issues in pharmacy and medicine: science and practice. 2024;17(1):31-4. Ukrainian. doi: https://doi.org/10.14739/2409-2932.2024.1.292556
Shevchenko VO, Shpychak OS, Rolik-Attia SM. [Risk assessment as an important factor in the process of developing the composition of the injection solution]. Pharmaceutical journal. 2023;78(5):53-61. Ukrainian. doi: https://doi.org/10.32352/0367-3057.5.23.06
Kolpakova OA, Kucherenko NV. [Study of stability of anti-scarring ointment with water-soluble protein-polysaccharidic complex of the fungus Pleurotus ostreatus during the storage]. Pharmaceutical journal. 2022;77(2):73-9. Ukrainian. doi: https://doi.org/10.32352/0367-3057.2.22.07
Řemínek R, Foret F. Capillary electrophoretic methods for quality control analyses of pharmaceuticals: A review. Electrophoresis. 2021;42(1-2):19-37. doi: https://doi.org/10.1002/elps.202000185
Luo X, Chen L, Yang J, Li S, Li M, Mo Q, et al. Electrochemically simultaneous detection of ascorbic acid, sulfite and oxalic acid on Pt-Pd nanoparticles/chitosan/nitrogen doped graphene modified glassy carbon electrode: A method for drug quality control. Microchem J. 2021;169:106623. doi: https://doi.org/10.1016/j.microc.2021.106623
Sardella M, Belcher G, Lungu C, Ignoni T, Camisa M, Stenver DI, et al. Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance. Ther Adv Drug Saf. 2021;12:20420986211038436. doi: https://doi.org/10.1177/20420986211038436
Das TK, Sreedhara A, Colandene JD, Chou DK, Filipe V, Grapentin C, et al. Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality. J Pharm Sci. 2022;111(4):868-86. doi: https://doi.org/10.1016/j.xphs.2021.09.030
Haji M, Kerbache L, Al-Ansari T. Food quality, drug safety, and increasing public health measures in supply chain management. Processes. 2022;10(9):1715. doi: https://doi.org/10.3390/pr10091715
Derzhavna Farmakopeia Ukrainy [The State Pharmacopoeia of Ukraine]. 2nd ed. Kharkiv, (UA): State Enterprise Ukrainian Scientific Pharmacopoeial Center of Medicines Quality; 2015. Ukrainian.
He S, Wu L, Li X, Sun H, Xiong T, Liu J, et al. Metal-organic frameworks for advanced drug delivery. Acta Pharm Sin B. 2021;11(8):2362-95. doi: https://doi.org/10.1016/j.apsb.2021.03.019
Separovic L, Simabukuro RS, Couto AR, Bertanha ML, Dias FR, Sano AY, et al. Measurement uncertainty and conformity assessment applied to drug and medicine analyses - a review. Crit Rev Anal Chem. 2023;53(1):123-38. doi: https://doi.org/10.1080/10408347.2021.1940086
Abuhejail RM, Alzoman NZ, Darwish IA. Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing. Molecules. 2023;28(20):7054. doi: https://doi.org/10.3390/molecules28207054
Eruaga MA, Itua EO, Bature JT. Enhancing medication quality control in Nigeria: a comprehensive analysis of regulatory challenges and solutions. International medical science research journal. 2024;4(3):284-94. doi: https://doi.org/10.51594/imsrj.v4i3.920
Bature JT, Eruaga MA, Itua EO. Integrating pharmacogenomic testing into personalized medicine practices in the USA: Implications for medication quality control and therapeutic efficacy. GSC Biol Pharm Sci. 2024;26(3):19-26. doi: https://doi.org/10.30574/gscbps.2024.26.3.0081
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 A. H. Kaplaushenko, S. O. Vasyuk, A. I. Avramenko, M. Zh. Koichev
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
